1. 364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC. (10th December 2020) Authors: Awad, Mark; Spigel, David; Garon, Edward; Waqar, Saiama; Lisberg, Aaron; Moles, Melissa; Tepper, Jennifer; Lamb, April; Wanamaker, Amy; Khondker, Zakaria; Srouji, John; Dong, Jesse; Poran, Asaf; Balogh, Kristen; Bushway, Meghan; DeMario, Mark; Srinivasan, Lakshmi; Gaynor, Richard; Govindan, Ramas... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O81 IMpower110: interim overall survival (OS) analysis of a phase III study of atezolizumab (ATEZO) monotherapy vs platinum-based chemotherapy (CHEMO) as first-line (1L) treatment in PD-L1–selected NSCLC. (15th April 2020) Authors: Herbst, Roy; Marinis, Filippo De; Giaccone, Giuseppe; Reinmuth, Niels; Vergnenegre, Alain; Barrios, Carlos; Morise, Masahiro; Font, Enriqueta; Andric, Zoran; Geater, Sarayut; Ozguroglu, Mustafa; Mocci, Simonetta; McCleland, Mark; Enquist, Ida; Komatsubara, Kim; Deng, Yu; Kuriki, Hiroshi; Wen, Xia... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 1 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non‐Small Cell Lung Cancer. (23rd August 2018) Authors: Buttigliero, Consuelo; Shepherd, Frances A.; Barlesi, Fabrice; Schwartz, Brian; Orlov, Sergey; Favaretto, Adolfo G.; Santoro, Armando; Hirsh, Vera; Ramlau, Rodryg; Blackler, Adele R.; Roder, Joanna; Spigel, David; Novello, Silvia; Akerley, Wallace; Scagliotti, Giorgio V. Journal: Oncologist Issue: Volume 24:Number 6(2019) Page Start: e251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗